Dehydropeptide-based plasmonic magnetogels: a supramolecular composite nanosystem for multimodal cancer therapy-Reference-Cited by-同舟云学术

Dehydropeptide-based plasmonic magnetogels: a supramolecular composite nanosystem for multimodal cancer therapy

Published:2020 Issue:1 Volume:8 Page:45-64
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Veloso Sérgio R. S.¹²³⁴^ORCID,Martins J. A.⁵²³⁴^ORCID,Hilliou Loic⁶⁷²⁸⁴,O. Amorim C.⁹¹⁰¹¹⁴,Amaral V. S.⁹¹⁰¹¹⁴,Almeida B. G.¹²³⁴^ORCID,Jervis Peter J.⁵²³⁴¹²,Moreira Rute¹²¹³¹⁴¹⁵¹⁶,Pereira David M.¹²¹³¹⁴¹⁵¹⁶^ORCID,Coutinho Paulo J. G.¹²³⁴^ORCID,Ferreira Paula M. T.⁵²³⁴,Castanheira Elisabete M. S.¹²³⁴^ORCID

Affiliation:

1. Centro de Física (CFUM)

2. University of Minho

3. 4710-057 Braga

4. Portugal

5. Centro de Química (CQUM)

6. Institute for Polymers and Composites/I3N

7. Department of Polymer Engineering

8. 4800-058 Guimarães

9. Physics Department and CICECO

10. University of Aveiro

11. 3810-193 Aveiro

12. REQUIMTE/LAQV

13. Lab of Pharmacognosy

14. Department of Chemistry

15. Faculty of Pharmacy

16. University of Porto

Abstract

Supramolecular plasmonic magnetogels comprising two different nanoparticle architectures were developed and evaluated as potential nanocarriers for multimodal cancer therapy with reversible photothermia capabilities and tuneable drug release.

Funder

Programa Operacional Temático Factores de Competitividade

Fundação para a Ciência e a Tecnologia

European Regional Development Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2020/TB/C9TB01900F

Reference94 articles.

1. Nanocarriers for cancer-targeted drug delivery